Abstract

【中文题目：2017 ASCO及WCLC晚期非鳞NSCLC抗血管生成治疗进展】 【中文关键词：肺肿瘤；抗血管生成治疗；表皮生长因子受体酪氨酸激酶抑制剂】.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29).
Emmanuelle Renaud ... Charles Ricordel
Translational lung cancer research | VOL. 12
Emmanuelle Renaud, et. al.Emmanuelle Renaud ... Charles Ricordel
01 Feb 2023
Therapeutic Effects of Pembrolizumab Combined with Paclitaxel and Cisplatin Chemotherapy on Advanced Non-Squamous Non-Small Cell Lung Cancer and Influencing Factors
G Wu
Indian Journal of Pharmaceutical Sciences | VOL. 83
G WuG Wu
01 Jan 2020
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Naoyuki Nogami ... Yuichi Takiguchi
Japanese journal of clinical oncology | VOL. 54
Naoyuki Nogami, et. al.Naoyuki Nogami ... Yuichi Takiguchi
09 Apr 2024
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trial
James Chih-Hsin Yang ... Keunchil Park
European Journal of Cancer | VOL. 50
James Chih-Hsin Yang, et. al.James Chih-Hsin Yang ... Keunchil Park
18 Jun 2014
View more papers

More From: Chinese Journal of Lung Cancer

Paper Title
Journal
Date
Author
Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations.
Guowei Zhang ... Zhiyong Ma
Chinese Journal of Lung Cancer | VOL. 25
Guowei Zhang, et. al.Guowei Zhang ... Zhiyong Ma
20 Sep 2022
Application of Immune Checkpoint Inhibitors in EGFR Mutant Advanced Non-small Cell Lung Cancer
Yujun Zheng ... Mingji Wang
Chinese Journal of Lung Cancer | VOL. 25
Yujun Zheng, et. al.Yujun Zheng ... Mingji Wang
20 Sep 2022
Association of CDH1, FANCB and APC Gene Polymorphisms with Lung Cancer Susceptibility in Chinese Population
Lianchun Su ... Jun Chen
Chinese Journal of Lung Cancer | VOL. 25
Lianchun Su, et. al.Lianchun Su ... Jun Chen
20 Sep 2022
Research Advances of Immunotherapy of Exosome PD-L1 in Non-small Cell Lung Cancer
Na Wang ...
Chinese Journal of Lung Cancer | VOL. 25
Na Wang, et. al.Na Wang ...
20 Sep 2022
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.